Zhiling Li

ORCID: 0000-0002-2667-3575 · 4 papers in corpus
observational 2025
Improved surgical outcomes in adenomyosis: a novel insight into the superiority of secretory phase adenomyomectomy
Archives of gynecology and obstetrics ·doi:10.1007/s00404-025-08084-6

OBJECTIVE: To evaluate whether the timing of adenomyomectomy within the menstrual cycle influences outcomes in patients with adenomyosis, and to assess whether surgery performed during the secretory phase offers clinical advantages over the…

observational 2023
Comparison of dual-trigger and human chorionic gonadotropin-only trigger among polycystic ovary syndrome couples who underwent controlled ovarian stimulation and intrauterine insemination: A retrospective cohort study
Medicine ·doi:10.1097/md.0000000000032867

The dual-trigger regime, consisting of gonadotrophin releasing hormone agonist and human chorionic gonadotropin (HCG), has been shown to offer advantage over the HCG-only trigger regime. However, little is known about the influence of dual-…

observational 2023
Hypersecretion of basal luteinizing hormone and an increased risk of pregnancy loss among women with polycystic ovary syndrome undergoing controlled ovarian stimulation and intrauterine insemination
Heliyon ·doi:10.1016/j.heliyon.2023.e16233

INTRODUCTION: The relationship between basal luteinizing hormone (LH) and reproductive outcomes in women with polycystic ovary syndrome (PCOS) undergoing intrauterine insemination (IUI) has remained largely unknown, warranting further inves…

lab-animal 2015
Effects of GnRH agonists on the expression of developmental follicular anti-mullerian hormone in varying follicular stages in cyclic mice in vivo
Molecular medicine reports ·doi:10.3892/mmr.2015.3993

Gonadotrophin‑releasing hormone (GnRH) agonists (GnRHa) have been widely used to induce a state of downregulation for in vitro fertilization, and its direct effects on the pituitary are well known. However, the effects of GnRHa on the expre…